Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry); By Function; By End Use; By Regions; Segment Forecast, 2023 – 2032

Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry); By Function; By End Use; By Regions; Segment Forecast, 2023 – 2032

The global pharmaceutical gelatin market size is expected treach USD 2.17 billion by 2032, according ta new study by Polaris Market Research. The report “Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Surce (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry); By Function; By End Use; By Regions; Segment Forecast, 2022 - 2032” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.

Pharmaceutical gelatin is a high molecular weight, delicate, water-soluble, colorless, and translucent substance obtained from the partial hydrolysis of collagen found in animal skin, bones, and white connective tissues. It is a non-toxic and absorbable substance extensively utilized in various pharmaceutical applications. Gelatin is commonly used as a suspending agent tstabilize pharmaceutical suspensions and produce capsules. Furthermore, it is an excellent source of protein and can be used as a substitute for plasma.

In surgical procedures, absorbable film and sponges contain gelatin. The gelatin market is driven by the increasing use of gelatin in the nutraceutical and pharmaceutical industries for manufacturing drugs, growing awareness of the importance of nutrition-rich foods, and the expanding senior population. However, the high cost of gelatin, which is heavily used in the outer covering of capsules, and the availability of substitute components hinder the market growth. Furthermore, the rising awareness of nutrition fortification in food presents an opportunity for future growth in this market.

Several opportunities for market expansion exist due tthe major market participants enhanced efforts tcreate distinctive gelatin capsule shells employing cutting-edge technology. For example, a digital health company, etectRx, Inc., has been conducting studies ttrack medication opioid users' observation with antiretroviral treatment while handling human immunodeficiency virus (HIV). In the ""MyTPill"" project, patient adherence will be evaluated using the System ID-Cap, which comprises a capsule of hard gelatin with the wireless detector of an ingestible and a wearable reader. These unprecedented steps will increase the use of gelatin in producing hard gelatin capsules (ID-Cap), accelerating market growth.

The production and supply chain of gelatin were significantly affected by COVID-19 as the import and export of gelatin-based products and capsules were suspended due tpandemic restrictions. Notably, gelatin was found tplay a vital role in COVID-19 treatment. For example, a PubMed study published in May 2022 revealed that adding gelatin tdrug delivery considerably improves protein stabilization and enhances the active protein fractions after nebulization, thus reducing medication dosages. In the post-pandemic era, the market is expected texperience growth due tincreased product launches, higher demand for pharmaceutical-grade gelatin, and increased research and development in gelatin-based products.

Report Highlights

The pharmaceutical gelatin market is categorized intvarious applications: hard capsules, soft gel capsules, tablets, absorbable hemostats, and others. The soft gel capsules segment is expected twitness the highest growth during the forecast period in the pharmaceutical gelatin market.

Porcine sources dominate the market share, with the main segments being pork, bovine skin, bone, marine, and poultry. The rapid manufacturing cycle and cost-effectiveness of using porcine sources are among the primary factors contributing tthe growth of this segment.

The North American region holds a significant position in the pharmaceutical gelatin market. The market growth in the area can be attributed tthe presence of a well-established pharmaceutical industry, increasing research and development activities, and rising demand for pharmaceutical products.

Polaris Market Research has segmented the Pharmaceutical Gelatin Market report based on source, function, end-use, and region:

Pharmaceutical Gelatin Market, Source Outlook (Revenue - USD Billion, 2019 - 2032)

Porcine

Bovine Skin

Bovine Bone

Fish

Poultry

Pharmaceutical Gelatin Market, Function Outlook (Revenue - USD Billion, 2019 - 2032)

Stabilizing

Thickening

Gelling

Pharmaceutical Gelatin Market, End-Use Outlook (Revenue - USD Billion, 2019- 2032)

Hard Capsule

Soft Capsule

Tablet

Absorbable Hemostat

Pharmaceutical Gelatin Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa